Xtant Medical Holdings, Inc. (XTNT) - Product Pipeline Analysis, 2016 Update

Report code: GDME9541PD

Publisher: GlobalData

Formats: PDF

Published: June 29, 2016

Number of pages: 31

Xtant Medical Holdings, Inc. (Xtant Medical), formerly Bacterin International Holdings, Inc. is a medical device company that develops class-leading regenerative medicine products and medical devices. The company offers products such as 3Demin, osteosponge, osteosponge SC, osteoselect DBM Putty, OsteoSTX, osteowrap, orbitalwrap HD, facet stabilization, milled cervical spacers, traditional allografts, hMatrix ADM, hMatrix PR ADM, and sports medicine. It utilizes sterile technology for producing bacterin products. The company also has its operational presence in Louisiana, Maryland, Oregon, Illinois, Delaware, California, Florida, and New York. Xtant Medical is headquartered in Belgrade, Montana, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Xtant Medical Holdings, Inc.

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reason To Buy

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Xtant Medical Holdings, Inc. Company Snapshot 6

Xtant Medical Holdings, Inc. Company Overview 6

Xtant Medical Holdings, Inc. Pipeline Products and Clinical Trials Overview 7

Xtant Medical Holdings, Inc. – Pipeline Analysis Overview 9

Key Facts 9

Xtant Medical Holdings, Inc. - Major Products and Services 10

Xtant Medical Holdings, Inc. Pipeline Products by Development Stage 11

Xtant Medical Holdings, Inc. Pipeline Products Overview 13

Anti-Microbial Coated GenerOs CF 13

Anti-Microbial Coated GenerOs CF Product Overview 13

Anti-Microbial Coated GenerOs SB Generator 14

Anti-Microbial Coated GenerOs SB Generator Product Overview 14

Disk Augmentation System 15

Disk Augmentation System Product Overview 15

Interbody Fusion Device 16

Interbody Fusion Device Product Overview 16

Lumbar Dynamic Posterior Stabilization Device 17

Lumbar Dynamic Posterior Stabilization Device Product Overview 17

Monetite Granules Based Bone Graft 18

Monetite Granules Based Bone Graft Product Overview 18

Next Generation Demineralized Bone Matrix Allograft 19

Next Generation Demineralized Bone Matrix Allograft Product Overview 19

OsteoSponge SC - Cartilage Re-generation Scaffold 20

OsteoSponge SC - Cartilage Re-generation Scaffold Product Overview 20

Xspan Laminoplasty Fixation System 21

Xspan Laminoplasty Fixation System Product Overview 21

XTANT 3D Printer 22

XTANT 3D Printer Product Overview 22

Xtant Medical Holdings, Inc. - Key Competitors 23

Xtant Medical Holdings, Inc. - Key Employees 24

Xtant Medical Holdings, Inc. - Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 26

Xtant Medical Holdings, Inc., Recent Developments 26

Jun 16, 2016: Xtant Medical Announces Changes to Its Executive Management and Board of Directors 26

May 26, 2016: Xtant Medical completes new accounts receivable revolver credit facility with Silicon Valley Bank 26

May 12, 2016: Xtant Medical Announces The FDA Clearance For The Posterior Cervical Screw Indication On Certex Spinal Fixation System 27

May 04, 2016: Xtant Medical Reports First Quarter 2016 Results 27

Apr 26, 2016: Xtant Medical Announces Montana Department of Commerce Grant Awards 28

Apr 19, 2016: Xtant Medical Pre-Announces First Quarter 2016 Revenue 28

Mar 30, 2016: Xtant Medical Announces FDA Clearance Of The Xspan Laminoplasty Fixation System 29

Mar 24, 2016: Xtant Medical Announces Distribution Agreement with Vivex Biomedical Bringing OsteoVive, a Cellular Allograft, to Market 29

Mar 03, 2016: Xtant Medical Receives CE Mark for Its Irix-A Stand Alone Anterior Lumbar Interbody Fusion Device 30

Mar 03, 2016: Xtant Medical Receives CE Mark for Its Aranax Cervical Plating System 30

Appendix 31

Methodology 31

About GlobalData 31

Contact Us 31

Disclaimer 31

List of Tables

List of Tables

Xtant Medical Holdings, Inc. Pipeline Products and Clinical Trials Overview 7

Xtant Medical Holdings, Inc. Pipeline Products by Equipment Type 7

Xtant Medical Holdings, Inc. Pipeline Products by Indication 8

Xtant Medical Holdings, Inc., Key Facts 9

Xtant Medical Holdings, Inc., Major Products and Services 10

Xtant Medical Holdings, Inc. Number of Pipeline Products by Development Stage 11

Xtant Medical Holdings, Inc. Pipeline Products Summary by Development Stage 12

Anti-Microbial Coated GenerOs CF - Product Status 13

Anti-Microbial Coated GenerOs CF - Product Description 13

Anti-Microbial Coated GenerOs SB Generator - Product Status 14

Anti-Microbial Coated GenerOs SB Generator - Product Description 14

Disk Augmentation System - Product Status 15

Disk Augmentation System - Product Description 15

Interbody Fusion Device - Product Status 16

Interbody Fusion Device - Product Description 16

Lumbar Dynamic Posterior Stabilization Device - Product Status 17

Lumbar Dynamic Posterior Stabilization Device - Product Description 17

Monetite Granules Based Bone Graft - Product Status 18

Monetite Granules Based Bone Graft - Product Description 18

Next Generation Demineralized Bone Matrix Allograft - Product Status 19

Next Generation Demineralized Bone Matrix Allograft - Product Description 19

OsteoSponge SC - Cartilage Re-generation Scaffold - Product Status 20

OsteoSponge SC - Cartilage Re-generation Scaffold - Product Description 20

Xspan Laminoplasty Fixation System - Product Status 21

Xspan Laminoplasty Fixation System - Product Description 21

XTANT 3D Printer - Product Status 22

XTANT 3D Printer - Product Description 22

Xtant Medical Holdings, Inc., Key Employees 24

Xtant Medical Holdings, Inc., Subsidiaries 25

List of Figures

List of Figures

Xtant Medical Holdings, Inc. Pipeline Products by Equipment Type 8

Xtant Medical Holdings, Inc. Pipeline Products by Development Stage 11

Save time and money with a subscription

Require regular access to company intelligence? Why not consider a cost-effective subscription platform and gain access to 250,000+ reports?

To find out more, click here or call +91 (0)40 4961 4567.

Single User License
Electronic PDF copy delivered via email.

Report can be used by individual purchaser only.

$750

Site License
Electronic PDF copy delivered via email.

Report can be shared by unlimited users within one corporate location,
e.g. a regional office.

$1500

Global License
Electronic PDF copy delivered via email.

Report can be shared globally by unlimited users within the purchasing corporation
e.g. all employees of a single company.

$2250

TOP